Theabrownin Induces Cell Apoptosis and Cell Cycle Arrest of Oligodendroglioma and Astrocytoma in Different Pathways

J Y Fu1, C X Jiang1, M Y Wu1

  • 1Institute of Developmental and Regenerative Biology, Zhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, China.

Insights

Theabrownin (TB), a compound from green tea, effectively reduced glioma cell viability and induced cell cycle arrest. These findings suggest TB as a promising new drug candidate for treating gliomas.

Area of Science:

  • Oncology
  • Natural Products Chemistry
  • Molecular Biology

Background:

  • Gliomas are aggressive brain tumors with limited treatment options.
  • Theabrownin (TB), a natural compound from green tea, shows potential as an antitumor agent.
  • The specific effects of TB on glioma cells remain largely unexplored.

Purpose of the Study:

  • To investigate the impact of Theabrownin (TB) on astroglioma and oligodendroglioma cells.
  • To elucidate the molecular mechanisms underlying TB's effects on glioma cell viability and proliferation.

Main Methods:

  • Treatment of HOG and U251 glioma cell lines with varying doses of TB.
  • Assessment of cell viability using cell counting assays.
  • Analysis of apoptosis-related proteins (active-Casp-3, Bax, Bcl-2, PTEN) via Western blotting.
  • Cell cycle analysis using flow cytometry.
  • Quantification of cell cycle regulatory proteins (c-myc, cyclins, CDKs, p21, p27, P53) via Western blotting.

Main Results:

  • TB significantly reduced the viability of HOG and U251 cells in a dose-dependent manner.
  • TB induced apoptosis by upregulating Bax, PTEN, and active-Casp-3, while downregulating Bcl-2.
  • TB caused cell cycle arrest at G1 phase in HOG cells and G2/M phase in U251 cells, involving differential regulation of key cell cycle proteins.
  • Mechanisms involved c-myc downregulation in HOG cells and P53 upregulation in U251 cells.

Conclusions:

  • Theabrownin exhibits significant antitumor activity against glioma cells.
  • TB induces glioma cell death and cell cycle arrest through distinct molecular pathways.
  • TB represents a potential novel therapeutic candidate for glioma treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K